MedTrace Logo

Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection

NCT03050879 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 266

Last updated 2025-04-24

No results posted yet for this study

Summary

The purpose of this study is to explore the clinical outcomes of Indocyanine Green Tracer using in laparoscopic gastrectomy with lymph node dissection for gastric adenocarcinoma（cT1-4a, N-/+, M0）.

Conditions

  • Stomach Neoplasms
  • Indocyanine Green

Interventions

DRUG

Indocyanine Green Tracer

Laparoscopic gastrectomy with lymph node dissection for gastric cancer using Indocyanine Green Tracer

Sponsors & Collaborators

  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Changming Huang, Professor · Fujian Medical University Union Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-15
Primary Completion
2019-07-13
Completion
2019-07-13

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03050879 on ClinicalTrials.gov